The data, similarly to our findings, imply that breast cancer and multiple myeloma cells are likely to reduce apoptosis and fortify themselves via autocrine IL-15 stimulation, thus becoming less dependent upon their microenvironment. The gene discussed is IL15; the disease is plasma cell myeloma.